Literature DB >> 12773258

Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation.

A Boland1, Y Dundar, A Bagust, A Haycox, R Hill, R Mujica Mota, T Walley, R Dickson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12773258     DOI： 10.3310/hta7150

Source DB:  PubMed          Journal:  Health Technol Assess        ISSN： 1366-5278            Impact factor:   4.014


× No keyword cloud information.
  20 in total

Review 1.  A review of health care models for coronary heart disease interventions.

Authors:  K Cooper; S C Brailsford; R Davies; J Raftery
Journal:  Health Care Manag Sci       Date:  2006-11

Review 2.  Thrombolysis: past, present, and future.

Authors:  D Gray
Journal:  Postgrad Med J       Date:  2006-06       Impact factor: 2.401

Review 3.  Streptokinase--the drug of choice for thrombolytic therapy.

Authors:  Adinarayana Kunamneni; Thaer Taleb Abed Abdelghani; Poluri Ellaiah
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300

4.  Reprogrammed streptokinases develop fibrin-targeting and dissolve blood clots with more potency than tissue plasminogen activator.

Authors:  I Y Sazonova; R A McNamee; A K Houng; S M King; L Hedstrom; G L Reed
Journal:  J Thromb Haemost       Date:  2009-06-30       Impact factor: 5.824

5.  Pharmacopolitics: reflections on a subspecialty of clinical pharmacology?

Authors:  Michael D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

6.  Zinc chelation promotes streptokinase-induced thrombolysis in vitro.

Authors:  Zihui Wang; Xinge Yu; Yang V Li
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-11-01

7.  Efficacy of fibrinolysis in the emergency department for acute myocardial infarction.

Authors:  G Lane; J Cuddihy; P Wright; D Doherty; A McShane
Journal:  Ir J Med Sci       Date:  2005 Jul-Sep       Impact factor: 1.568

8.  Primary Angioplasty for the Treatment of Acute ST-Segment Elevated Myocardial Infarction: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2004-08-01

9.  Sensitivity of treatment recommendations to bias in network meta-analysis.

Authors:  David M Phillippo; Sofia Dias; A E Ades; Vanessa Didelez; Nicky J Welton
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2017-12-06       Impact factor: 2.483

10.  Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men.

Authors:  S G Wannamethee; P H Whincup; A G Shaper; A Rumley; L Lennon; G D O Lowe
Journal:  J Thromb Haemost       Date:  2009-08-11       Impact factor: 5.824
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.